1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer
Download real time

930.00 5.25 (0.57%)

29.77% Fall from 52W High

1.9M NSE+BSE Volume

NSE 30 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
21S
2W
3O
5T
93,579.8

Market Cap

High in industry
20.3

PE TTM

Below industry Median
1.2

PEG TTM

PEG TTM is much higher than 1
4.3

Price to Book

Above industry Median
0.8

Beta 1Year

Very Low volatility


Board Meetings - Zydus Lifesciences Ltd.

The latest board meeting for Zydus Lifesciences Ltd. took place on 20 May 2025, for the purpose of Audited Results & Final Dividend

Share
Ex-date Purpose Notes
20 May 2025 Audited Results & Final Dividend -
05 Feb 2025 Quarterly Results -
12 Nov 2024 Quarterly Results -
09 Aug 2024 Quarterly Results -
17 May 2024 Audited Results & Final Dividend -
09 Feb 2024 Quarterly Results & Buy Back of shares -
07 Nov 2023 Quarterly Results -
11 Aug 2023 Quarterly Results -
18 May 2023 Audited Results & Final Dividend -
03 Feb 2023 Quarterly Results -
11 Nov 2022 Quarterly Results -
10 Aug 2022 Quarterly Results -
20 May 2022 Audited Results, Dividend & Buy Back -
03 Feb 2022 Quarterly Results -
29 Oct 2021 Quarterly Results -
11 Aug 2021 Quarterly Results -
27 May 2021 Audited Results & Final Dividend -
05 Feb 2021 Quarterly Results -
02 Nov 2020 Quarterly Results -
05 Aug 2020 Quarterly Results -
19 Jun 2020 Audited Results -
16 Mar 2020 Interim Dividend -
05 Feb 2020 Quarterly Results -
13 Nov 2019 Quarterly Results -
09 Aug 2019 Quarterly Results -
29 May 2019 Audited Results & Final Dividend -
07 Feb 2019 Quarterly Results -
03 Nov 2018 Quarterly Results -
13 Aug 2018 Quarterly Results -
25 May 2018 Audited Results, Dividend & Others -
08 Feb 2018 Quarterly Results -
14 Nov 2017 Quarterly Results -
11 Aug 2017 Quarterly Results -
26 Jun 2017 Others To raise funds by issue of Equity Shares / Convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR, subject to approval of the shareholders.
27 May 2017 Audited Results -
07 Mar 2017 Interim Dividend -
31 Jan 2017 Quarterly Results -
17 Nov 2016 Scheme of Arrangement -
26 Oct 2016 Quarterly Results -
03 Aug 2016 Quarterly Results -
13 May 2016 Audited Results & Others To raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR for an aggregate amount upto Rs.10,000 Crores,
08 Mar 2016 Interim Dividend -
05 Feb 2016 Quarterly Results -
22 Oct 2015 Quarterly Results -
12 Aug 2015 Quarterly Results Approved the sub-division (split) of one equity share of the Company having a face value of Rs.5/- into five equity-shares of face of Rs.1/- each.
15 May 2015 Audited Results & Dividend To delist Equity Shares of the Company from Ahmedabad Stock Exchange Limited (ASE), in view of non-trading of Equity Shares of the Company on ASE since last so many years.
10 Feb 2015 Quarterly Results -
06 Nov 2014 Quarterly Results -
30 Jul 2014 Quarterly Results -
16 May 2014 Audited Results & Dividend -
07 Feb 2014 Quarterly Results -
31 Oct 2013 Quarterly Results -
30 Aug 2013 Audited merged accounts To consider and approve the audited merged accounts for the financial year ended on March 31, 2013.
07 Aug 2013 Quarterly Results -
30 May 2013 Audited Results & Interim Dividend -
22 Apr 2013 Scheme of Amalgamation -
08 Feb 2013 Quarterly Results -
07 Nov 2012 Quarterly Results -
06 Aug 2012 Quarterly Results -
10 May 2012 Audited Results & Dividend -
07 Feb 2012 Quarterly Results -
10 Nov 2011 Quarterly Results -
19 Jul 2011 Quarterly Results -
06 May 2011 Audited Results & Dividend -
18 Jan 2011 Quarterly Results & Others The Board will elect the Chairman of the Investors' Grievance Committee.
19 Oct 2010 Quarterly Results -
27 Jul 2010 Quarterly Results -
29 Apr 2010 Audited Results & Dividend -
25 Feb 2010 Increase the Authorised Capital & Bonus To increase the Authorised Share Capital of the Company from Rs. 700/- Millions to Rs. 1100/- Millions & to issue of Bonus Equity Shares in the ratio 1:2 of Rs. 5/- each fully paid-up Equity Shares.
25 Jan 2010 Quarterly Results -
27 Oct 2009 Quarterly Results -
27 Jul 2009 Quarterly Results -
28 Apr 2009 Audited Results & Dividend -
27 Jan 2009 Quarterly Results -
22 Oct 2008 Quarterly Results -
29 Jul 2008 Quarterly Results -
04 Jul 2008 Composite Scheme of Arrangement To approve the "Composite Scheme of Arrangement between Cadila, Carnation and Zydus Hospitals and Medical Research Pvt Ltd".
17 Jun 2008 To consider Re-structure of CPB To consider options to consolidate / restructure the Consumer Products business of the group, including its listed subsidiary, namely Carnation Nutra-Analogue Foods Ltd.
29 Apr 2008 Audited Results & Dividend -
31 Jan 2008 Quarterly Results -
26 Oct 2007 Quarterly Results -
31 Jul 2007 Quarterly Results -
17 Jun 2007 To consider issue f FCCB's inter alia, to consider, to issue Foreign Currency Convertible Bonds (FCCBs) / ADRs / GDRs, etc. subject to approval of shareholders and such other statutory authorities.
26 Apr 2007 Audited Results & Dividend -
22 Jan 2007 Quarterly Results -
31 Oct 2006 Quarterly Results -
28 Jul 2006 Quarterly Results -
28 Apr 2006 Bonus issue -
28 Jan 2006 Quarterly Results -
22 Oct 2005 Quarterly Results -
26 Jul 2005 Quarterly Results -
29 Apr 2005 Accounts & Dividend -
27 Jan 2005 Quarterly Results -
25 Oct 2004 Quarterly Results -
26 Jul 2004 Quarterly Results -
26 Apr 2004 Dividend & Accounts -
12 Feb 2004 Amalgamation Amalgamation of Banyan Chemicals Ltd., (the wholly owned subsidiary of the company) with the company.
20 Jan 2004 Quarterly Results -
20 Oct 2003 Quarterly Results -
16 Aug 2003 Accounts & Dividend -